肿瘤标志物预测孤立性肺结节恶性概率模型的建立与初步评价
Establishment and preliminary evaluation of a model for predicting the malignant probability of solitary pulmonary nodule with tumor markers

DOI: 10.6040/j.issn.1671-7554.0.2016.828

Keywords: 肿瘤标志物,孤立性肺结节,Logistic回归模型,
Solitary pulmonary nodule,Tumor markers,Logistic regression model

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]	David PN, Alexander AB, Heber M, et al. Recommendations for the management of subsolid pulmonary nodules detected at CT:A statement from the fleischner society[J]. Radiology, 2013, 266(1): 304-317.
[2]	Bai C, Choi CM, Chu CM, et al. Evaluation of pulmonary nodules: clinical practice consensus guidelines for Asia[J]. Chest, 2016, 150(4): 877-893.
[3]	中华医学会呼吸病学分会肺癌学组,中国肺癌防治联盟专家组. 肺部结节诊治中国专家共识[J].中华结核和呼吸杂志, 2015, 38(4): 249-254.
[4]	周清华,范亚光,王颖,等.中国肺部结节分类、诊断与治疗指南(2016年版)[J].中国肺癌杂志,2016, 19(12): 793-798. ZHOU Qinghua, FAN Yaguang, WANG Ying, et al. China national guideline of classification, diagnosis and treatment for lung nodules(2016 version)[J]. Chin J Lung Cancer, 2016, 19(12): 793-798.
[5]	Swensen SJ, Silverstein MD, Ilstrup DM, et al. The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules[J]. Arch Intern Med, 1997,157(8): 849-855.
[6]	Gould MK, Ananth L, Barnett PC. A clinical model to estimate the pretest probability of lung cancer in patients with solitary pulmonary nodules[J]. Chest, 2007, 131(2): 383-388.
[7]	田蓉,苏鸣岗,田野,等.影响孤立性肺结节良恶性鉴别的因素分析及恶性可能性预测[J].四川大学学报(医学版), 2012, 43(3): 404-408. TIAN Rong, SU Minggang, TIAN Ye, et al. Development of a predicting model to estimate the probability of malignancy of solitary pulmonary nodules[J]. Journal of Sichuan University(Medical Science Edition), 2012, 43(3): 404-408.
[8]	Gurney JW. Determining the likelihood of malignancy in solitarypulmonary nodules with Bayesian analysis: Part I Theory[J]. Radiology, 1993, 186(2): 405-413.
[9]	Siegelman SS, Khouri NF, Leo FP, et al. Solitary pulmonary nodules: CT assessment[J]. Radiology, 1986, 160(2): 307-312.
[10]	杨德松,李运,刘军,等.孤立性肺结节直径大小与临床及病理关系的初步研究[J].中国肺癌杂志, 2010, 13(6): 607-611. YANG Desong, LI Yun, LIU Jun, et al. Study on solitary pulmonary nodules: correlation between diameter and clinical manifestation and pathological features[J]. Chin J Lung Cancer, 2010, 13(6): 607-611.
[11]	上官红,肖伟,董亮,等.血清CYFRA21-1、NSE和CEA在肺癌诊断和评估预后中的临床价值[J].山东大学学报(医学版), 2010, 48(12): 134-137. SHANGGUAN Hong, XIAO Wei, DONG Liang, et al. Clinical value of serum CYFRA 21-1, NSE and CEA in the diagnosis and prognosis of lung cancer[J]. Journal of Shandong University(Health Science), 2010, 48(12): 134-137.
[12]	冯国双,刘德平.医学研究中的logistic回归分析及SAS实现[M].北京:北京大学医学出版社,2012.
[13]	Gould MK, Donington J, Lynch WR, et al. Evaluation of individuals with pulmonary nodules:when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines[J]. Chest, 2013, 143(5): e93S-e120S.
[14]	MacMahon H, Austin JH, Gamsu G, et al. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society[J]. Radiology, 2005, 237(2): 395-400.
[15]	倪莲芳,刘新民.血清肿瘤标记物对孤立性肺结节良恶性的诊断价值[J].北京大学学报(医学版), 2014, 46(5): 707-710. NI Lianfang, LIU Xinmin. Diagnostic value of serum tumor markers in differentiating malignant from benign solitary pulmonary nodules[J]. Journal of Peking University(Health Sciences), 2014, 46(5): 707-710.
[16]	Gould MK, Fletcher J, Lannettoni MD, et al. Evaluation of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines(2nd edition)[J]. Chest, 2007, 132(3 Suppl): 108S-130S.
[17]	Callister ME, Baldwin DR, Akram AR, et al. British Thoracic Society guidelines for the investigation and management of pulmonary nodules[J]. Thorax, 2015, 70(2): ii1-ii54.
[18]	Slatore CG, Horeweg N, Jett JR, et al. An official American Thoracic Society research statement: a research framework for pulmonary nodule evaluation and management[J]. Am J Respir Crit Care Med, 2015, 192(4): 500-514.
[19]	Wood DE. National Comprehensive Cancer Network(NCCN)clinical practice guidelines for lung cancer screening[J]. Thorac Surg Clin, 2015, 25(2): 185-197.
[20]	李运,陈克终,隋锡朝,等.孤立性肺结节良恶性判断数学预测模型的建立[J].北京大学学报(医学版), 2011, 43(3): 450-454. LI Yun, CHEN Kezhong, SUI Xizhao, et al. Establishment of a mathematical prediction model to evaluate the probability of malignancy or benign in patients with solitaty pulmonary nodules[J]. Journal of Peking University(Health Sciences), 2011, 43(3): 450-454.
[21]	Harders SW. LUCIS: lung cancer imaging studies[J]. Dan Med J, 2012, 59(11): B4542.
[22]	罗疏薇,欧春萍,张莉萍,等.应用ROC曲线评价CEA、CYFRA21-1、SCC对非小细胞肺癌的诊断价值[J].重庆医学, 2011, 40(3): 250-252, 255. LUO Shuwei, OU Chunping, ZHANG Liping, et al. Applicationi of ROC curve to evaluate CEA, CYFRA21-1, SCC to non-small cell lung cancer diagnosis value[J]. Chongqing Medicine, 2011, 40(3): 250-252, 255.
[23]	冯香梅,王国庆,陈瑛,等.血清肿瘤标志物在肺癌诊断中的应用价值[J].中国肿瘤临床, 2010, 37(6):331-334. FENG Xiangmei, WANG Guoqing, CHEN Ying, et al. Diagnostic value of serum tumor markers for lung cancer[J]. Chinese Journal of Clinical Oncology, 2010, 37(6):331-334.
[24]	Satoh H, Ishikawa H, Kurishima K, et al. Cut of levels of NSE to differentiate SCLC from NSCLC[J]. Oncol Rep, 2002, 9(3): 581-583.
[25]	张菁,马靖,王广发.实性和亚实性肺结节临床处理:ACCP最新肺结节诊疗指南简介[J]. 中华结核和呼吸杂志, 2014, 37(3): 202-205.

Full-Text